THEUER CHARLES
SEC insider (Form 3/4/5 filer). CIK 0001631338. Director at 4D Molecular Therapeutics, Inc. (FDMT). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in EMERYVILLE, CA.
Companies THEUER CHARLES has filed insider reports for
- 4D Molecular Therapeutics, Inc. (FDMT): Director
THEUER CHARLES
CIK: 0001631338
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FDMT
4D Molecular Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 17, 2026FDMT
4D Molecular Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
50K shares- - Dec 12, 2025FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect9.3K shares at avg. $1.14$11K - Jun 17, 2025FDMT
4D Molecular Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
22.5K shares-
1-3 of 3 transactions